Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Calithera Biosciences stock opened at $0.05 on Wednesday. The stock’s 50 day moving average price is $0.20 and its 200 day moving […]

Related Keywords

California ,United States ,South San Francisco ,Calithera Biosciences ,Goldman Sachs Group Inc ,Renaissance Technologies ,Vanguard Group Inc ,Affinity Asset Advisors ,Calithera Biosciences Company Profile ,Calithera Biosciences Inc ,Alyeska Investment Group ,Free Report ,Sachs Group ,Asset Advisors ,Get Free Report ,Calithera Biosciences Daily ,Nasdaq Cala ,Ocala ,Medical ,Initiated Coverage ,Stocknews Com ,